Explore our validated contract research frameworks and high-purity natural extracts designed for leading dermatological and cosmetic brands worldwide.
In modern dermatological brand engineering, moving from unverified herbal claims to reproducible bio-cellular efficacy is imperative. We bridge scientific phytochemistry with clean-beauty compliance.
Herbal active volatility represents the greatest hazard in OEM contract manufacturing. MedGence applies strict chromatographic fingerprinting (HPTLC/HPLC) to lock in batch-to-batch chemical stability across variable seasonal harvests.
Traditional raw botanical infusions fail to cross the stratum corneum barrier. Our delivery architecture relies on advanced liposomal encapsulation, nano-emulsification, and supercritical sub-micron dispersion for profound dermal penetration.
Clean formulation mandates zero compromise on cytotoxicity or sensitization. We deliver LD50 toxicology metrics, genetic screening (Ames test), and 3D reconstructed human epidermis (RhE) irritation assays prior to manufacturing.
Operating from Changsha, Hunan, MedGence leverages integrated pharmaceutical engineering to supply scalable, high-yield active ingredients and finished formulations across global territories.
Equipped with closed-loop multi-stage countercurrent extraction and membrane separation systems, our facility achieves up to 98% bioactive recovery with reduced volatile solvent usage.
GMP-certified manufacturing suites equipped with laminar airflow systems ensure that creams, concentrated serums, and micro-powders meet rigorous microbiological specifications.
Our origin-screening protocols evaluate soil geochemistry, altitude, and harvest timings across Chinese indigenous regions to ensure consistent constituent purity from root to bottle.
Discover how our proprietary research architecture transitions classic pharmacopeia into hyper-targeted, computationally designed bio-active skincare solutions.
In silico ligand-protein docking to identify botanical compounds matching human collagenase (MMP-1), tyrosinase, and elastase inhibition targets with ultra-high specificity.
Bioconversion of complex herbal polysaccharides via probiotic bio-fermentation, yielding lower molecular weight peptides that double transdermal bio-absorption.
Multi-omics transcriptomics validation on 3D pigmented and vascularized tissue organoids, offering rigorous phenotypic proof to substantiate claim verification.
Continuous-flow green water extraction alongside upcycled agro-botanical streams, providing worldwide brand owners with certified eco-sustainable supply chains.
Enterprise cosmetic procurement demands rapid speed-to-market, unquestioned IP confidentiality, and complete traceability. Here is how MedGence compares to traditional cosmetic OEM lines.
| Evaluation Parameter | MedGence Pharmaceutical-Grade CDMO | Standard Cosmetic OEM Factory |
|---|---|---|
| Efficacy Substantiation | In vitro cell assays, animal models, and Phase I–IV human clinical studies | Primarily sensory or generic third-party baseline testing |
| Quality Control Standard | HPLC/HPTLC chromatographic fingerprinting and single-herb traceability | Standard viscosity, pH, and basic microbial testing |
| Formula Confidentiality | Strict contract research framework (NDA); complete trade secret isolation | Shared generic chassis; risk of identical regional formulas |
| Customization Depth | Custom molecular screening, tailored solvent extraction, custom actives | Catalog-only off-the-shelf formulation selection |
| Global Regulatory Defense | Complete safety dossier: LD50, genotoxicity, REACH/MoCRA technical backup | Basic Safety Data Sheets (SDS) and certificate of analysis (COA) |
Navigating global regulatory authorities requires robust chemical dossier backing. MedGence acts as your dedicated scientific compliance partner for key market registrations.
Full support for Modernization of Cosmetics Regulation Act (MoCRA) demands, including Product Listing, Good Manufacturing Practice (GMP) alignment, safety substantiation files, and fragrance allergen disclosures.
Preparation of comprehensive Cosmetic Product Safety Reports (CPSR Part A & B), toxicological hazard assessments, and SVHC declarations under EU Regulation (EC) No 1223/2009.
Deep familiarity with NMPA raw-material safety code registrations, botanical ingredient standardization files, and human efficacy evaluation test trials conducted under accredited CNAS laboratories.
Our formulations are built upon proven clinical foundations, having supported top pharmaceutical groups, university teaching hospitals, and state medical departments.
Over 14+ years, our Changsha R&D center has completed medical investigations for 83 classic Traditional Chinese Medicine formulas, secured 56 hospital preparation registrations, and engineered 22 innovative healthcare candidates alongside recognized institutions:
Key technical insights to guide your cosmetic procurement, R&D evaluation, and CDMO contract scheduling.
Traditional OEM manufacturers typically mix pre-purchased standard bases with off-the-shelf catalog actives. A CRO/CDMO integrated facility such as MedGence initiates research at the botanical level: screening raw biomass, executing quantitative HPLC analysis, evaluating transdermal carrier dynamics, running preclinical safety assays, and validating finished claims via human clinical trials.
Natural plant extracts naturally fluctuate in chemical profile based on harvest season, solar exposure, and soil minerals. Through HPTLC and HPLC fingerprint matching, we generate a standardized chemical blueprint for every active batch. This ensures active markers (such as polyphenols, ginsenosides, or triterpenes) remain quantitatively identical across every commercial release.
We supply raw active ingredients as concentrated standardized liquids, micro-milled powders, phytosterols, pastes, and lipophilic volatile oils. For finished commercial skincare, we manufacture facial serums, multi-lamellar creams, micro-emulsions, ampoules, hydrogel sheets, exfoliating gels, and restorative ointments under cleanroom conditions.
We operate under strict bilateral Non-Disclosure Agreements (NDAs). All entrusted contract research data, separation parameters, yield metrics, and final formulations remain the exclusive intellectual property of the commissioning client, protected by encrypted IT partitions and dedicated isolated production suites.
Directly source validated testing suites and contract research modules to accelerate your next skincare line launch.
